2021
DOI: 10.3390/s21082869
|View full text |Cite
|
Sign up to set email alerts
|

An Intelligent In-Shoe System for Gait Monitoring and Analysis with Optimized Sampling and Real-Time Visualization Capabilities

Abstract: The deterioration of gait can be used as a biomarker for ageing and neurological diseases. Continuous gait monitoring and analysis are essential for early deficit detection and personalized rehabilitation. The use of mobile and wearable inertial sensor systems for gait monitoring and analysis have been well explored with promising results in the literature. However, most of these studies focus on technologies for the assessment of gait characteristics, few of them have considered the data acquisition bandwidth… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
14
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
2
2
1

Relationship

5
5

Authors

Journals

citations
Cited by 19 publications
(17 citation statements)
references
References 43 publications
0
14
0
Order By: Relevance
“…Wearable inertial measurement units (IMUs) address some of these challenges inherent to 3D motion capture and also offer potential for cost-effective portable clinical gait analysis (Wu et al, 2021 ; McDevitt et al, 2022 ). Wearable devices such as the APDM Opal IMU-based system have been promoted for use in clinical populations to monitor gait and mobility in individuals with neurodegenerative conditions such as Parkinson’s disease and have recently been advanced as digital biomarker endpoints for clinical trials (Mancini et al, 2015 ; Mancini and Horak, 2016 ).…”
Section: Introductionmentioning
confidence: 99%
“…Wearable inertial measurement units (IMUs) address some of these challenges inherent to 3D motion capture and also offer potential for cost-effective portable clinical gait analysis (Wu et al, 2021 ; McDevitt et al, 2022 ). Wearable devices such as the APDM Opal IMU-based system have been promoted for use in clinical populations to monitor gait and mobility in individuals with neurodegenerative conditions such as Parkinson’s disease and have recently been advanced as digital biomarker endpoints for clinical trials (Mancini et al, 2015 ; Mancini and Horak, 2016 ).…”
Section: Introductionmentioning
confidence: 99%
“…All walking data were collected by the wearable gait analysis system Nushu developed by Magnes AG [33]. It consists of a pair of shoes and a mobile (iOS) application.…”
Section: Data Collection Systemmentioning
confidence: 99%
“…All walking data were collected by the wearable gait analysis system Nushu developed by Magnes AG [21]. It consists of a pair of shoes and a mobile (iOS) application.…”
Section: B Data Collection Systemmentioning
confidence: 99%